首页> 外国专利> COMPOSITIONS, INCLUDING TAGASEROD IN SEPARATELY OR IN COMBINATION WITH A PROTON PUMP INHIBITOR, FOR TREATMENT OR PREVENTION OF GASTRONOMAL INJURIES

COMPOSITIONS, INCLUDING TAGASEROD IN SEPARATELY OR IN COMBINATION WITH A PROTON PUMP INHIBITOR, FOR TREATMENT OR PREVENTION OF GASTRONOMAL INJURIES

机译:用于治疗或预防胃肠道损伤的组合物,包括他哥罗碱单独或与质子泵抑制剂组合使用

摘要

1. A pharmaceutical composition comprising tegaserod and a proton pump inhibitor. ! 2. The pharmaceutical composition according to claim 1, wherein the proton pump inhibitor is selected from the group consisting of omeprazole, esomeprazole, lanzoprazole, rabeprazole, pantoprazole and leminoprazole. ! 3. The pharmaceutical composition according to claim 1, where the proton pump inhibitor is omeprazole. ! 4. A method of treating or preventing damage to the gastrointestinal tract in a subject in need of such treatment, comprising administering to the subject an effective amount of tegaserod. !5. The method according to claim 4, where damage to the gastrointestinal tract is induced by the administration of a non-steroidal anti-inflammatory drug (NSAID). ! 6. The method according to claim 4, where tegaserod is administered in combination with a proton pump inhibitor. ! 7. The method according to claim 6, where the proton pump inhibitor is selected from the group consisting of omeprazole, esomeprazole, lanzoprazole, rabeprazole, pantoprazole and leminoprazole. ! 8. The method according to claim 6, where the proton pump inhibitor is omeprazole. ! 9. The method according to claim 6, where tegaserod is first introduced, and then a proton pump inhibitor. ! 10. The method according to claim 6, where the proton pump inhibitor is first introduced, and then tegaserod. ! 11. The method according to claim 6, where tegaserod and a proton pump inhibitor are administered simultaneously. ! 12. The use according to claim 4, where the damage to the gastrointestinal tract is selected from the group including damage to the mucous membrane, dysfunction of the muscles of the gastrointestinal tract, gastritis, peptic erosion, ulcers and pathological changes in the gastrointestinal tract. ! 13. A method for treating pain and / or inflammation in a subject, comprising administering to a subject in need of such treatment a therapeutic
机译:1.一种药物组合物,其包含替加色罗和质子泵抑制剂。 ! 2.根据权利要求1的药物组合物,其中质子泵抑制剂选自奥美拉唑,埃索美拉唑,兰索拉唑,雷贝拉唑,pan托拉唑和莱米诺拉唑。 ! 3.根据权利要求1的药物组合物,其中质子泵抑制剂是奥美拉唑。 ! 4.一种在需要这种治疗的受试者中治疗或预防对胃肠道的损害的方法,该方法包括向该受试者施用有效量的替加色罗。 5。 5.根据权利要求4所述的方法,其中通过施用非甾体抗炎药(NSAID)来诱导对胃肠道的损害。 ! 6.根据权利要求4的方法,其中替加色罗与质子泵抑制剂联合施用。 ! 7.根据权利要求6的方法,其中所述质子泵抑制剂选自奥美拉唑,埃索美拉唑,兰索拉唑,雷贝拉唑,pan托拉唑和莱米诺拉唑。 ! 8.根据权利要求6的方法,其中所述质子泵抑制剂是奥美拉唑。 ! 9.根据权利要求6的方法,其中先引入替加色罗,然后引入质子泵抑制剂。 ! 10.根据权利要求6的方法,其中首先引入质子泵抑制剂,然后引入替加色罗。 ! 11.根据权利要求6的方法,其中替加色罗和质子泵抑制剂同时施用。 ! 12.根据权利要求4的用途,其中所述胃肠道损伤选自粘膜损伤,胃肠道肌肉功能障碍,胃炎,消化道糜烂,溃疡和胃肠道病理变化。 。 ! 13.一种用于治疗受试者的疼痛和/或炎症的方法,包括向需要这种治疗的受试者施用治疗剂。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号